Interstitial Lung Disease Induced by Pazopanib Treatment

Although pneumothorax has been reported to be a major pulmonary adverse event in patients treated with pazopanib, a multikinase inhibitor, drug-induced interstitial lung disease (DILD) has not been reported. A 74-year-old Japanese man who received pazopanib for the treatment of femoral leiomyosarcom...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Intern Med
Päätekijät: Ide, Shotaro, Sakamoto, Noriho, Hara, Shintaro, Hara, Atsuko, Kakugawa, Tomoyuki, Nakamura, Yoichi, Futsuki, Yoji, Izumikawa, Koichi, Ishimatsu, Yuji, Yanagihara, Katsunori, Mukae, Hiroshi
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: The Japanese Society of Internal Medicine 2017
Aiheet:
Case Report
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5313429/
https://ncbi.nlm.nih.gov/pubmed/28050004
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia